Guha Asthagiri Arunkumar

Author

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Fatima Amanat, Guha A. Arunkumar, Guha Asthagiri Arunkumar

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai BOKU University National Institutes of Health Moderna Therapeutics (United States)National Institute of Allergy and Infectious Diseases

About

Guha Asthagiri Arunkumar is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.1K
2	Immunology	5	5	1K
3	Public Health	1	1	51
4	Epidemiology	1	1	51
5	Population Health Sciences	1	1	51

Guha Asthagiri Arunkumar

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
A serological assay to detect SARS-CoV-2 seroconversion in humans Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, Nature Medicine Viral DiagnosticsDiagnostic TestSerologic TestingMolecular DiagnosticsSerological Assay	2020	1.9K
SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup Daniel Stadlbauer, Fatima Amanat, Veronika Chromikova, Current Protocols in Microbiology Viral DiagnosticsImmunodeficienciesImmunologyViral PathogenesisImmunodominance	2020	805
A serological assay to detect SARS-CoV-2 seroconversion in humans Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier,	2020	397
Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City Daniel Stadlbauer, Jessica Tan, Kaijun Jiang, Nature	2020	154
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge Alec W. Freyn, Caroline Atyeo, Patricia L. Earl, Science Translational Medicine	2023	94
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates Eric M. Mucker, Alec W. Freyn, Sandra L. Bixler, Cell VaccinologyVaccinationVaccine DevelopmentVaccinia Ankara VaccinationVaccine Target	2024	91
Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice Guha Asthagiri Arunkumar, Andriani Ioannou, Teddy John Wohlbold, Journal of Virology	2019	83
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, Nature VaccinationVaccine DevelopmentWuhan-1 Mrna VaccinesImmunologyVaccine Design	2024	71
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge Meagan McMahon, Guha Asthagiri Arunkumar, Wen‐Chun Liu, Frontiers in Immunology	2019	54
Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City Daniel Stadlbauer, Jessica Tan, Kaijun Jiang, Sars-cov-2 SeroprevalenceNyc Metropolitan AreaLongitudinal MonitoringImmunodeficienciesCovid-19 Pandemic	2020	51

Page 1